Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL4521594 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
α2B-adrenoceptor/Alpha-2b adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1942] [GtoPdb: 26] [UniProtKB: P18089] | ||||||||
ChEMBL | Selectivity interaction (GPCR panel (PDSP screen)) EUB0000309b ADRA2B | B | 5.34 | pKi | 4580 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | GPCRScan assay: inhibition of Alpha2B | B | 5.37 | pKi | 4315.19 | nM | Ki | Data for DCP probe BAY-1797 |
ChEMBL | GPCRScan assay: inhibition of Alpha2B | B | 5.37 | pKi | 4285.88 | nM | Ki | Data for DCP probe BAY-1797 |
carbonic anhydrase 2/Carbonic anhydrase II in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL205] [GtoPdb: 3092] [UniProtKB: P00918] | ||||||||
ChEMBL | Inhibition of carbonic anhydrase 2 (unknown origin) | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
DAT/Dopamine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL238] [GtoPdb: 927] [UniProtKB: Q01959] | ||||||||
ChEMBL | Antagonist activity at human DAT receptor by scintillation counting method | B | 5.66 | pIC50 | 2170 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
ChEMBL | Selectivity interaction (Lead profiling screen (Eurofins, GPCRs, ion channels, kinases and transporters)) EUB0000309b SLC6A3 | B | 5.66 | pIC50 | 2170 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibition of human ERG | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
P2X1/P2X purinoceptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2094] [GtoPdb: 478] [UniProtKB: P51575] | ||||||||
ChEMBL | Antagonist activity at human P2X1 receptor | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
ChEMBL | Selectivity interaction (Lead profiling screen (Eurofins, GPCRs, ion channels, kinases and transporters)) EUB0000309b P2RX1 | B | 4.3 | pIC50 | >50000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
P2X2/P2X purinoceptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2531] [GtoPdb: 479] [UniProtKB: Q9UBL9] | ||||||||
ChEMBL | Antagonist activity at human P2X2 receptor | B | 4.52 | pIC50 | >30000 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
P2X3/P2X purinoceptor 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2998] [GtoPdb: 480] [UniProtKB: P56373] | ||||||||
ChEMBL | Antagonist activity at human P2X3 receptor | B | 5.08 | pIC50 | 8300 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
ChEMBL | Selectivity interaction (Lead profiling screen (Eurofins, GPCRs, ion channels, kinases and transporters)) EUB0000309b P2RX3 | B | 5.08 | pIC50 | 8300 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
P2X4/P2X purinoceptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2104] [GtoPdb: 481] [UniProtKB: Q99571] | ||||||||
ChEMBL | Selectivity interaction (Lead profiling screen (Eurofins, GPCRs, ion channels, kinases and transporters)) EUB0000309b P2RX4 | B | 4.52 | pIC50 | >30000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | Ephys Qpatch Assay with 1321 N1 Astrocytoma cells | B | 6.49 | pIC50 | 320 | nM | IC50 | Data for DCP probe BAY-1797 |
ChEMBL | Antagonist activity at human P2X4 receptor tranfected in human 1321N1 cells assessed as inhibition of inhibition of ATP-evoked current at -90 mV holding potential by Qpatch method | B | 6.49 | pIC50 | 320 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
ChEMBL | Ephys Qpatch Assay with HEK293 cells | B | 6.56 | pIC50 | 274 | nM | IC50 | Data for DCP probe BAY-1797 |
ChEMBL | Affinity Phenotypic Cellular interaction (Ephys Qpatch Assay in HEK293 cells) EUB0000309b P2RX4 | F | 6.56 | pIC50 | 274 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay | B | 6.68 | pIC50 | 211 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
ChEMBL | Fluorometric imaging plate reader (FLIPR)-based Ca2+ assay with HEK293 cells | B | 6.68 | pIC50 | 211 | nM | IC50 | Data for DCP probe BAY-1797 |
ChEMBL | Antagonist activity at human P2X4 receptor | B | 6.68 | pIC50 | 211 | nM | IC50 | Eur J Med Chem (2022) 231: 114162-114162 [PMID:35123298] |
ChEMBL | Affinity On-target Cellular interaction (FLIPR assay (inhibition of ATP-induced calcium influx in HEK293 cells, stably transfected with human P2X4 receptor)) EUB0000309b P2RX4 | B | 6.68 | pIC50 | 211 | nM | IC50 | Affinity On-target Cellular Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | Antagonist activity at human P2X4 receptor tranfected in human 1321N1 cells assessed as inhibition of Mg-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay | B | 6.97 | pIC50 | 108 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
ChEMBL | Fluorometric imaging plate reader (FLIPR)-based Ca2+ assay with 1321 N1 Astrocytoma cells | B | 6.97 | pIC50 | 108 | nM | IC50 | Data for DCP probe BAY-1797 |
GtoPdb | - | - | 7 | pIC50 | 100 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
P2X4/P2X purinoceptor 4 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2176849] [GtoPdb: 481] [UniProtKB: Q9JJX6] | ||||||||
ChEMBL | Antagonist activity at mouse P2X4 receptor tranfected in human 1321N1 cells assessed as inhibition of Mg-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay | B | 6.95 | pIC50 | 112 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
P2X4/P2X purinoceptor 4 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2818] [GtoPdb: 481] [UniProtKB: P51577] | ||||||||
ChEMBL | Antagonist activity at rat P2X4 receptor tranfected in human 1321N1 cells assessed as inhibition of Mg-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay | B | 6.63 | pIC50 | 233 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
P2X7/P2X purinoceptor 7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4805] [GtoPdb: 484] [UniProtKB: Q99572] | ||||||||
ChEMBL | Antagonist activity at human P2X7 receptor | B | 4.97 | pIC50 | 10600 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
ChEMBL | Selectivity interaction (Lead profiling screen (Eurofins, GPCRs, ion channels, kinases and transporters)) EUB0000309b P2RX7 | B | 4.97 | pIC50 | 10600 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
ChEMBL | Selectivity interaction (GPCR panel (PDSP screen)) EUB0000309b HTR2C | B | 5.19 | pKi | 6520 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | GPCRScan assay: inhibition of 5-HT2C | B | 5.19 | pKi | 6519.91 | nM | Ki | Data for DCP probe BAY-1797 |
ChEMBL | GPCRScan assay: inhibition of 5-HT2C | B | 5.23 | pKi | 5888.44 | nM | Ki | Data for DCP probe BAY-1797 |
σ2/Sigma intracellular receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4105907] [GtoPdb: 2553] [UniProtKB: Q5BJF2] | ||||||||
ChEMBL | GPCRScan assay: inhibition of Sigma 2 | B | 5.36 | pKi | 4344.21 | nM | Ki | Data for DCP probe BAY-1797 |
ChEMBL | Selectivity interaction (GPCR panel (PDSP screen)) EUB0000309b TMEM97 | B | 5.36 | pKi | 4340 | nM | Ki | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | GPCRScan assay: inhibition of Sigma 2 | B | 5.38 | pKi | 4168.69 | nM | Ki | Data for DCP probe BAY-1797 |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]